Skip to main navigation Skip to search Skip to main content

Crushing peanuts: From peanut allergy sensitization to innovative allergen immunotherapy strategies

Research output: PhD ThesisPhd-Thesis - Research and graduation internal

Abstract

Peanut allergy belongs to the group of most severe food allergies. Currently, there is only one active treatment for peanut allergy that has been approved by the FDA and EMA. This is an oral immunotherapy treatment that has been proven to be sufficiently safe and effective to induce desensitization, but treatment protocols can take up to three to five years, severe side-effects often
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • University of Amsterdam
Supervisors/Advisors
  • van Ree, Ronald, Supervisor
  • van Kooyk, Y., Co-supervisor, External person
Award date5 Jul 2024
Print ISBNs9789465060606
Publication statusPublished - 2024

Fingerprint

Dive into the research topics of 'Crushing peanuts: From peanut allergy sensitization to innovative allergen immunotherapy strategies'. Together they form a unique fingerprint.

Cite this